Literature DB >> 1738296

Endothelin-1- and endothelin-3-induced vasorelaxation via common generation of endothelium-derived nitric oxide.

A Namiki1, Y Hirata, M Ishikawa, M Moroi, J Aikawa, K Machii.   

Abstract

The vasorelaxant effects by endothelin-1 (ET-1) and endothelin-3 (ET-3), and their mechanisms of action were studied in isolated porcine pulmonary arterial strips. ET-1 and ET-3 dose-dependently (10(-9) - 10(-8) M) relaxed vascular strips precontracted with norepinephrine only in the presence of endothelium. The maximal vasorelaxant effect by ET-1 was about 70% of that by ET-3. The ET-1- and ET-3- induced vasorelaxation was blocked by NG-nitro-L-arginine, an inhibitor of nitric oxide synthesis, and methylene blue, an inhibitor of soluble guanylate cyclase. The present data suggest that vascular smooth muscle relaxation induced by ET-1 and ET-3 is mainly ascribed to synthesis and release of nitric oxide from L-arginine in endothelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738296     DOI: 10.1016/0024-3205(92)90470-a

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

1.  Salt-sensitive hypertension in endothelin-B receptor-deficient rats.

Authors:  C E Gariepy; T Ohuchi; S C Williams; J A Richardson; M Yanagisawa
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Differential localization of endothelin ETA and ETB binding sites in human placenta.

Authors:  R A Rutherford; J Wharton; A McCarthy; L Gordon; M H Sullivan; M G Elder; J M Polak
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

3.  Investigation of the contributions of nitric oxide and prostaglandins to the actions of endothelins and sarafotoxin 6c in rat isolated perfused lungs.

Authors:  H Lal; B Woodward; K I Williams
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

4.  Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease.

Authors:  Mohamed A Saleh; Jennifer S Pollock; David M Pollock
Journal:  J Pharmacol Exp Ther       Date:  2011-04-06       Impact factor: 4.030

5.  Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.

Authors:  Y Hirata; T Emori; S Eguchi; K Kanno; T Imai; K Ohta; F Marumo
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

Authors:  H Moritoki; H Miyano; S Takeuchi; M Yamaguchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

7.  Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects.

Authors:  L L Thomsen; H K Iversen; C Emmeluth; P Bie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

8.  Pharmacodynamic/pharmacogenomic modeling of insulin resistance genes in rat muscle after methylprednisolone treatment: exploring regulatory signaling cascades.

Authors:  Zhenling Yao; Eric P Hoffman; Svetlana Ghimbovschi; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Gene Regul Syst Bio       Date:  2008-04-23

9.  Effects of cyclic intermittent hypoxia on ET-1 responsiveness and endothelial dysfunction of pulmonary arteries in rats.

Authors:  Zhuo Wang; Ai-Ying Li; Qiu-Hong Guo; Jian-Ping Zhang; Qi An; Ya-jing Guo; Li Chu; J Woodrow Weiss; En-Sheng Ji
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Brain size reductions associated with endothelin B receptor mutation, a cause of Hirschsprung's disease.

Authors:  Ko-Chin Chen; Zan-Min Song; Geoffrey D Croaker
Journal:  BMC Neurosci       Date:  2021-06-19       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.